Intracellular calcium mobilization is an important early event involve
d in T cell activation. The endogenous opioid peptide beta-endorphin i
s known to modulate immune functions that depend on T cell activation,
therefore its effect on intracellular calcium mobilization was invest
igated. The intracellular calcium concentration ([Ca2+]i) of T cell-en
riched splenocytes was measured by flow cytofluorometric analysis usin
g the calcium-sensitive dye, Fluo-3. By gating on the T cell marker, T
hy-1, a 95%-pure population of T cells was identified for study. Cells
preincubated with beta-endorphin showed significantly enhanced [Ca2+]
i responses to the mitogen, Concanavalin A (Con A). This was detectabl
e with concentrations of beta-endorphin as low as 10(-13) M; maximal e
nhancement required 10(-10) to 10(-9) M doses. The efficacy of beta-en
dorphin was dependent on the duration of pretreatment. beta-Endorphin
amplified the Con A-induced increase in [Ca2+]i by reducing the lag ti
me for the response to Con A and by increasing the mean [Ca2+]i of the
cells. N-Ac-beta-endorphin, which shows minimal potency at neuronal o
piate receptors, was unable to substitute for beta-endorphin. Naltrind
ole, a highly selective delta opiate receptor antagonist, inhibited th
e action of beta-endorphin, whereas a selective mu opiate receptor ant
agonist was ineffective. Although less potent than beta-endorphin, the
delta opiate receptor agonist D-Ala(2)-D-Leu(5)-enkephalin also signi
ficantly enhanced [Ca2+]i responses. In summary, concentrations of bet
a-endorphin, within the physiological range found in the systemic circ
ulation, modulate the increase in T cell [Ca2+]i induced by Con A. Bot
h the efficacy of D-Ala(2)-D-Leu(5)-enkephalin alone and the antagonis
m of beta-endorphin by naltrindole suggest that a delta-type opiate re
ceptor may mediate these effects.